Status:
COMPLETED
Injection Therapy in Patients With Lateral Epicondylitis
Lead Sponsor:
Hacettepe University
Conditions:
Lateral Epicondylitis
Tennis Elbow
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Lateral epicondylitis is a painful enthesopathy of the common extensor tendon at the lateral part of the elbow, with a prevalence of 1-3 % in the general population. In the treatment of lateral epicon...
Detailed Description
Lateral epicondylitis and other chronic tendinopathies are now understood to be non-inflammatory conditions characterized by collagen degeneration, fibroblast proliferation, mucoid degeneration and ne...
Eligibility Criteria
Inclusion
- aged 20-60 years,
- had a clinical diagnosis of lateral epicondylitis, defined as pain over the lateral humeral epicondyle of at least 6 months' duration,
- provoked by palpation and resisted wrist/middle finger extension or gripping,
- participants needed to score at least 30/100 on Visual analogue scale (VAS),
- be able to understand enough Turkish to complete the outcome questionnaire.
Exclusion
- Any treatment for their elbow pain by a health care practitioner within the preceding 6 months,
- Concomitant neck or other arm pain causing disability or requiring treatment within the last 6 months,
- Clinical evidence of other primary sources of lateral elbow pain,
- Upper limb fractures within the preceding 10 years,
- Prior elbow surgery
- Elbow steroid injection in the past 3 months
- Systemic inflammatory disorder or malignancy,
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
May 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 25 2018
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04395417
Start Date
May 2 2018
End Date
September 25 2018
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hakan Apaydın
Ankara, Turkey (Türkiye), 06560